H. Bachelez

40 papers receiving 1.5k citations

H. Bachelez's Hit Papers

Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials 2018 · 470 citations
4700+2+5Years since publication100200300400

Peers

H. Bachelez
Comparison fields: 5 of 61
  • Dermatology 542
  • Immunology 1.2k
  • Pathology and Forensic Medicine 193
  • Rheumatology 157
  • Physiology 221
Replace Mary Flack with:
Mary Flack United States
Isabelle Hampele United States
Gregory Kricorian United States
Paolo Dapavo Italy
J.M.P.A. van den Reek Netherlands
Kristina P. Callis United States
Sophie Hugot Switzerland
Talia M. Muram United States
T.N. Dam Denmark
Yaowei Zhu United States
H. Bachelez relative to Mary Flack United States Mary Flack's profile →
Citations per field
00.5×1.6×
Mary Flack · 1×
Citations per year

Countries citing papers authored by H. Bachelez

Since Specialization
Citations

This map shows the geographic impact of H. Bachelez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Bachelez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Bachelez more than expected).

Fields of papers citing papers by H. Bachelez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Bachelez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Bachelez. The network helps show where H. Bachelez may publish in the future.

Co-authors

The 25 scholars most cited alongside H. Bachelez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with H. Bachelez Line = papers co-authored together H. Bachelez links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
Hit paper breakdown →
2018470
2 2021206
3 201983
4 202082
5 202175
6 202070
7 201959
8 201857
9 202156
10 202153
11 201945
12 202241
13 201937
14 202226
15 201825
16 202216
17 202015
18 202314
19 202410
20
EFFICACY AND SAFETY OF RISANKIZUMAB: RESULTS FROM TWO DOUBLE-BLIND, PLACEBO- AND USTEKINUMAB-CONTROLLED, PHASE 3 TRIALS IN MODERATE-TO-SEVERE PLAQUE PSORIASIS
201810

About H. Bachelez

H. Bachelez is a scholar working on Immunology, Dermatology, Oncology, Epidemiology and Physiology, having authored 43 papers that have together received 1.5k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (33 papers), Dermatology and Skin Diseases (7 papers), Cytokine Signaling Pathways and Interactions (5 papers), Hidradenitis Suppurativa and Treatments (3 papers), Autoimmune Bullous Skin Diseases (3 papers), Asthma and respiratory diseases (3 papers), Spondyloarthritis Studies and Treatments (2 papers) and Colorectal and Anal Carcinomas (2 papers). The work is most often cited by research in Dermatology (542 citations), Immunology (1.2k citations), Pathology and Forensic Medicine (193 citations), Rheumatology (157 citations) and Physiology (221 citations). H. Bachelez has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Mark Lebwohl, L. Puig, A. David Burden, Andrew Blauvelt, Kenneth B. Gordon, Kim Papp, Bruce Strober, Mamitaro Ohtsuki, Ziqian Geng and Joaquin Valdes. Their work appears in journals such as Journal of Investigative Dermatology, British Journal of Dermatology, Journal of the European Academy of Dermatology and Venereology, Experimental Dermatology and The Journal of Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact